World Vaccine
Congress 2022
“We’re seeing unprecedented vaccine developments driving new opportunities and highlighting ongoing challenges across the vaccine and disease prevention ecosystem.”
- 9:10 AM ET: “How Can We Build a More Resilient Public Health Infrastructure for Vaccines?” - Loren Becker
- 11:40 AM ET: “Data-Driven Health Advocacy to Inform Vaccine Policy Reforms” - Jason Hall
Our cross-functional team will be available to share their thinking relative to novel platform technologies, regulatory and policy evolution, commercialization lifecycles, flexible vaccine manufacturing capabilities, supply chain enhancements, and disparities in vaccination coverage and immunization rate recovery.
Meet Our
Experts
Associate Principal, Policy
Expertise: R&D-enabling policies and incentives, global regulatory pathways, global epidemic preparedness, cross-sector partnership
Consultant II, Policy
Expertise: Federal and state level policy, Medicare/Medicaid coverage, vaccine financing, and immunization information systems
Managing Director, Policy
Expertise: Product development, commercialization, policy, influenza, respiratory syncytial virus infections, COVID-19
Consultant II, Policy
Expertise: Immunization program development, global vaccine delivery, monitoring and evaluation, access pathways for novel immunization products
Managing Director, Market Access & Reimbursement
Expertise: Adult and pediatric influenza vaccines launch and commercialization, market access and payer strategy, development and execution
Master the
Evolving Market
Avalere provides life sciences organizations partnership and guidance across the vaccine development and commercialization continuum.
